Clinical Trial

Early Identification of Markers in Alzheimer's Families / ALFA

Study acronym: ALFA Cohort
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The ALFA study is a long term, prospective, observational study of AD patients' adult children aimed at studying and characterizing key physio-pathological features of the preclinical phase of AD.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2015-06-25; most recent amendment 2025-05-27.
Status change: Recruiting → Active, Not Recruiting 2021-06-08
Status change: Not Yet Recruiting → Recruiting 2017-03-01
Trial Details
NCT Number NCT02485730
Lead Sponsor Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Collaborators: Obra Social La Caixa, Spain
Conditions Alzheimer's Disease
Enrollment 419 participants
Start Date 2016-10-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-31